C. Lees et al., PLACENTAL NITRIC-OXIDE PRODUCTION AND UMBILICAL ARTERY VASCULAR IMPEDANCE IN EARLY-PREGNANCY, Obstetrics and gynecology, 91(5), 1998, pp. 761-765
Objective: To evaluate whether the vasorelaxant molecule nitric oxide
(NO) and its second messenger cyclic guanosine monophosphate (cGMP) mo
dulate the reduction in resistance within the fetoplacental circulatio
n that occurs during the first trimester of pregnancy. Methods: We stu
died 27 women undergoing termination of pregnancy for psychosocial ind
ications between 9 and 15 weeks' gestation. Each had ultrasound dating
of the fetus and Doppler umbilical artery (UA) now investigation imme
diately before the operation. Placental tissue was assayed for nitric
oxide synthase (NOS) activity and cGMP content. Results: Both UA pulsa
tility index (PI) and placental endothelial NOS activity decreased sig
nificantly with advancing gestation (r = -.52 and -.41, respectively).
Umbilical PI correlated positively with endothelial NOS activity and
cGMP level. Multiple linear regression analysis indicated that cGMP co
ntributed most strongly to UA PI (P < .001). Conclusion: Our findings
suggest somewhat paradoxically that NOS activity and cGMP levels are h
ighest in the early gestations, when umbilical PI is also high, and de
crease as umbilical PI decreases. Further studies are required to dete
rmine whether the predominant effect of NO is that of a vascular relax
ant or a modulator of new villous vessel formation. (C) 1998 by The Am
erican College of Obstetricians and Gynecologists.